Gainers

• Abivax (NASDAQ:ABVX) stock rose 13.7% to $130.65 during Monday's pre-market session. The company's market cap stands at $8.9 billion.
• Scinai Immunotherapeutics (NASDAQ:SCNI) stock increased by 11.27% to $0.88. The company's market cap stands at $2.7 million.
• Edgewise Therapeutics (NASDAQ:EWTX) stock increased by 9.9% to $28.08. The company's market cap stands at $2.7 billion.
• Equillium (NASDAQ:EQ) shares moved upwards by 9.56% to $1.26. The market value of their outstanding shares is at $70.0 million.
• Tharimmune (NASDAQ:THAR) shares increased by 9.48% to $2.54. The market value of their outstanding shares is at $81.3 million.
• Radiopharm Theranostics (NASDAQ:RADX) shares moved upwards by 8.86% to $5.65. The market value of their outstanding shares is at $40.3 million.

Losers

• DBV Technologies (NASDAQ:DBVT) stock decreased by 8.6% to $20.8 during Monday's pre-market session. The market value of their outstanding shares is at $913.4 million.
• Impact BioMedical (AMEX:IBO) stock declined by 7.55% to $0.6. The market value of their outstanding shares is at $7.9 million.
• Intercure (NASDAQ:INCR) stock declined by 7.36% to $1.26. The market value of their outstanding shares is at $74.3 million.
• BeyondSpring (NASDAQ:BYSI) shares fell 6.81% to $2.19. The market value of their outstanding shares is at $96.6 million.
• Minerva Neurosciences (NASDAQ:NERV) shares fell 6.44% to $3.78. The company's market cap stands at $28.2 million.
• Pluri (NASDAQ:PLUR) stock fell 5.79% to $3.26. The company's market cap stands at $32.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.